Abstract
A new synthetic protocol has been developed to provide entry into a series of novel tricyclic aryltriazole‐3‐thiones analogs. The classical reaction conditions of subjecting an arylhydrazide with thiophosgene to form the thioisocyanate intermediate and ultimately the corresponding aryltriazole‐3‐thione framework were not successful. However, using a combination of carbon disulfide and 1,8‐diazabicyclo[5.4.0]undec‐7‐ene (DBU) to form the thioisocyanate intermediate was found to produce the novel tricyclic aryltriazole‐3‐thiones (5, 8a–c) in good yield.
Keywords: